XML 47 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2019
Dec. 30, 2018
Dec. 31, 2019
Dec. 30, 2018
Mar. 31, 2019
Cash flows from operating activities          
Net earnings $ 27,305 $ 48,614 $ 138,639 $ 142,081  
Adjustments to reconcile net earnings to net cash provided by operating activities:          
Depreciation and amortization     65,788 42,511  
Write-off of assets relating to exit activities and other     10,024 4,498  
Derivatives not designated in hedging relationships:          
Net losses     517 390  
Cash settlements     (599) (865)  
Provision for doubtful accounts     2,922 849  
Deferred income taxes     (20,948) (222)  
Non-cash interest expense     1,160 953  
Stock-based compensation     14,759 14,587  
Gain on disposal of property, plant, and equipment     (112) (157)  
Changes in assets and liabilities, net of effects of acquisitions:          
Accounts receivable     58,779 21,860  
Inventories     (24,888) (36,440)  
Prepaid and other current assets     (6,977) (12,507)  
Other assets     3,686 (1,260)  
Accounts payable     (44,885) (649)  
Accrued expenses     (7,295) 14,306  
Other liabilities     (14,738) (23,511)  
Net cash provided by operating activities     175,832 166,424  
Cash flows from investing activities          
Capital expenditures     (60,936) (52,672)  
Purchase of businesses     (176,548) (650,000)  
Insurance proceeds relating to property, plant and equipment     403 0  
Proceeds from disposal of property, plant, and equipment     2,718 549  
Net cash used in investing activities     (234,363) (702,123)  
Cash flows from financing activities          
Net repayments on short-term debt     (17,632) (13,564)  
Proceeds from 2017 Term Loan     0 299,105  
Repayments of 2017 Term Loan     (11,276) 0  
Debt issuance costs     (4,607) (1,235)  
Option proceeds     505 9,044  
Payment of taxes related to net share settlement of equity awards     (6,281) (3,384)  
Purchase of treasury stock     (34,561) (25,000)  
Dividends paid to stockholders     (22,299) (22,280)  
Other     586 29  
Net cash provided by financing activities     33,435 451,215  
Effect of exchange rate changes on cash and cash equivalents     (1,606) (40,476)  
Net decrease in cash and cash equivalents     (26,702) (124,960)  
Cash and cash equivalents at beginning of period     299,212 522,118 $ 522,118
Cash and cash equivalents at end of period $ 272,510 397,158 272,510 397,158 $ 299,212
Non-cash investing and financing activities:          
Common stock issued as partial consideration for Alpha acquisition   $ 100,000 0 100,000  
Amended Credit Facility, due 2022          
Cash flows from financing activities          
Proceeds from borrowings     326,700 454,500  
Repayments of 2017 Revolver borrowings     (497,700) (246,000)  
4.375% Senior Notes due 2027          
Cash flows from financing activities          
Proceeds from borrowings     $ 300,000 $ 0